BetterLife/Altum Merger ‘Triggered By Early COVID-19 Promise’
BetterLife’s CEO Explains Altum Acquisition Logic
Created when BetterLife bought Altum at end-July, the merged entity will now focus on advancing the acquired group’s lead asset, an inhaled form of its patented interferon a2b product, as an early treatment for COVID-19.
